Three-stage expansion of humans across Eurasia and into the Americas
This is a fairly good paper. Many articles in the literature either date human expansions by genetic methods (which tell us about the age of common ancestors, or the accumulated genetic variation and its characteristics -e.g., linkage disequilibrium- but tell us little about where the ancestors lived), or by geo-demographic methods (which tell us about how populations grow and expand on the map given various parameter settings), or by archaeological methods (which record the spatio-temporal occurrence of sites, but are difficult to interpret and are subject to various biases).
The current paper combines the latter two methods to present a picture of the spread of humans across northeastern Eurasia (from southern Siberia) and eventually into the Americas. The point of origin (southern Siberia) is inferred via the dating of earliest archaeological sites, population growth and expansion is modeled via a simple diffusion equation, which is reality-checked via calibrations at other sites.
The authors make a good point about the mess that population genetics is with respect to dating human movements, so their decision to avoid it is understandable. However, genetics will eventually be able to complement the other two approaches, by the study of ancient DNA from the different sites (whenever they are associated with human remains). So far, ancient DNA in the region has been limited to Holocene remains, which postdate the events of interest, but if 30,000 year old Kostenki can yield useful results, I don’t see why human remains from northeastern Eurasia cannot, as conditions for DNA preservation there (=cold) are good.
While archaeological dates (which are based on physics and have small confidence intervals) are far more secure than genetic ones, they have the problem of “who done it”, as we can never be sure that the occupants of an early site are the same people as the later occupants of the same site. This can be done -to an extent- with craniometry, the fourth method of estimation human movements, but (a) interpreting population continuity in the face of ongoing adaptation of the human neurocranium is difficult and (b) you can get DNA from very incomplete bone and tooth remains, but you need a mostly complete skull to make statistical use of it using craniometry.
There have been long debates about the identity of the Paleondians, the long-skulled early inhabitants of the Americas, that do not resemble modern Amerindians, but DNA analysis of several ancient examples from both north and south America has revealed similar types of DNA as those found in the current inhabitants.
PLoS ONE 5(8): e12472. doi:10.1371/journal.pone.0012472
Archaeological Support for the Three-Stage Expansion of Modern Humans across Northeastern Eurasia and into the Americas
Marcus J. Hamilton, Briggs Buchanan
Abstract
Background
Understanding the dynamics of the human range expansion across northeastern Eurasia during the late Pleistocene is central to establishing empirical temporal constraints on the colonization of the Americas [1]. Opinions vary widely on how and when the Americas were colonized, with advocates supporting either a pre-[2] or post-[1], [3], [4], [5], [6] last glacial maximum (LGM) colonization, via either a land bridge across Beringia [3], [4], [5], a sea-faring Pacific Rim coastal route [1], [3], a trans-Arctic route [4], or a trans-Atlantic oceanic route [5]. Here we analyze a large sample of radiocarbon dates from the northeast Eurasian Upper Paleolithic to identify the origin of this expansion, and estimate the velocity of colonization wave as it moved across northern Eurasia and into the Americas.
Methodology/Principal Findings
We use diffusion models [6], [7] to quantify these dynamics. Our results show the expansion originated in the Altai region of southern Siberia ~46kBP , and from there expanded across northern Eurasia at an average velocity of 0.16 km per year. However, the movement of the colonizing wave was not continuous but underwent three distinct phases: 1) an initial expansion from 47-32k calBP; 2) a hiatus from ~32-16k calBP, and 3) a second expansion after the LGM ~16k calBP. These results provide archaeological support for the recently proposed three-stage model of the colonization of the Americas [8], [9]. Our results falsify the hypothesis of a pre-LGM terrestrial colonization of the Americas and we discuss the importance of these empirical results in the light of alternative models.
Conclusions/Significance
Our results demonstrate that the radiocarbon record of Upper Paleolithic northeastern Eurasia supports a post-LGM terrestrial colonization of the Americas falsifying the proposed pre-LGM terrestrial colonization of the Americas. We show that this expansion was not a simple process, but proceeded in three phases, consistent with genetic data, largely in response to the variable climatic conditions of late Pleistocene northeast Eurasia. Further, the constraints imposed by the spatiotemporal gradient in the empirical radiocarbon record across this entire region suggests that North America cannot have been colonized much before the existing Clovis radiocarbon record suggests.
Link


NIH Orders Halt To Embryonic Stem Cell Research
“Responding to a court order issued a week ago, the National Institutes of Health (NIH) on Friday ordered intramural researchers studying human embryonic stem cells (hESCs) to shut down their experiments. NIH’s action — probably unprecedented in its history — is a response to a preliminary injunction on 23 August from US District Judge Royce Lamberth. The judge ruled that the Obama policy allowing NIH funding to be used to study hESC lines violates a law prohibiting the use of federal funds to destroy embryos.”
When inclusive fitness is right and when it can be wrong (van Veelen 2010)
I’ve been doing a little reading to put the recent
Nowak et al. paper in context, and I came across another interesting recent critique of kin selection and its limitations. This is a fascinating area of study, and the fact that theoretical arguments have continued so long since the introduction of the inclusive fitness concept tells me that it is perplexing even for experts.
In the interest of clearness, here is Figure 1 from the paper, which gives a nice graphical representation of the cost-benefit relationship.
In this figure: “c the net cost of the behaviour to the acting individual, and b the aggregated benefits to the others.”
I’ll keep on thinking about both papers before I write anything more on the subject.
Journal of Theoretical BiologyVolume 259, Issue 3, 7 August 2009, Pages 589-600
Group selection, kin selection, altruism and cooperation: When inclusive fitness is right and when it can be wrong
Matthijs van Veelen
Group selection theory has a history of controversy. After a period of being in disrepute, models of group selection have regained some ground, but not without a renewed debate over their importance as a theoretical tool. In this paper I offer a simple framework for models of the evolution of altruism and cooperation that allows us to see how and to what extent both a classification with and one without group selection terminology are insightful ways of looking at the same models. Apart from this dualistic view, this paper contains a result that states that inclusive fitness correctly predicts the direction of selection for one class of models, represented by linear public goods games. Equally important is that this result has a flip side: there is a more general, but still very realistic class of models, including models with synergies, for which it is not possible to summarize their predictions on the basis of an evaluation of inclusive fitness.
Link


Y-chromosome haplogroup I and heart disease
There was a recent study on AIDS progression and Y-chromosome haplogroups. There is a new one on haplogroup I and coronary heart disease. I haven’t tracked down the article yet, but here is the press release from the European Society of Cardiology:
Scientists in the UK have shown that genetic variations in the Y chromosome affect a male’s risk of coronary heart disease. It is well known that males have a higher incidence of coronary heart disease than females due, in part, to the Y chromosome they inherit from their fathers. To investigate the role of the Y chromosome further, a team from the University of Leicester carried out research to determine whether genetic variations in the Y-chromosome affect risk for males.
Not all Y chromosomes are the same. There are variants within the male gender called “Y-haplogroups”, which are usually associated with specific geographic regions and tend to indicate the origin of the ancestral line. Professor Nilesh Samani explains the background to the project that was funded by the British Heart Foundation, “We set out to determine if men with differing types of Y chromosome were at differing risk of heart disease. We tested nearly 3,000 British males, and found that those carrying the I-haplogroup variant had a 55 percent higher risk of coronary heart disease.”
Of the 3,000 men tested, 1,295 were the cohort group of those with coronary heart disease and the rest were the control group. The Y-haplogroup was identified in all men, and the results showed that those in the I-haplogroup had an approximately 55 percent higher risk of coronary heart disease compared to the others. The association of the I-haplogroup with coronary heart disease was independent of, and not explained by, traditional heart risk factors such as cholesterol, high blood pressure and smoking.
Commonly found in central, eastern and northern Europe, the I-haplogroup is carried by about 13 percent of British men. Its origin is thought to be of the Gravettian culture, which arrived in Europe from the Middle East about 25,000 years ago. Since the I-haplogroup is not so prevalent in southern parts of Europe, an interesting speculation is whether it contributes to the higher levels of coronary heart disease in the north compared to the south – however, this requires further research and testing.
What is clear from this study though, is that men carrying the I-haplogroup are more likely to suffer from coronary heart disease than men with other Y-haplogroups.


BibTex citations available from SpringerLink
With the new version of SpringerLink that runs the journal’s website you can now get citations for articles in BibTex format, for easy inclusion in new articles prepared with LaTex. From the main page you can get to article listings through the search field or links such as Online First Articles or Current Issue. Then when you click on a particular article’s title you’ll get a page with the abstract and (among other things) an “EXPORT CITATION” link. Click that and then set the options as follows:
Export: Citation Only
Select Format: Plain Text
Select Citation Manager: BibTex
Then when you click “
EXPORT CITATION” it will download a text file containing the citation in BibTex.
The other options should help those of you using other citation formats or citation managers, but since several people had specifically requested support for BibTex I’m quite happy to see that this is working.
New Libertas Website
Libertas has recently launched a new and improved website which better suits the needs of all our users. Some of the new features include:
Better navigation
Navigation of the site was designed with simplicity in mind to ensure users can browse the site with ease. There are separate tabs for Journals, Author Resources, About Us, Peer Reviewers and News which contains all information relevant to each section.
Search
We have implemented a powerful search function based on Google which makes searching for articles and other information a breeze. The function has been placed in the website banner so you can perform searches at any time within the site.

Author information
There is a now a separate section for authors, which is accessed through the Author Resources tab. All information specifically for authors can be found here which includes our manuscript and resubmission preparation guides, optional services and much more including a video which demonstrates how to submit a manuscript.
Redesigned journal home pages
There are separate tabs displayed on each journal’s home page which contains detailed information on the journal. The tabs include Aims & Scopes, Call for Papers, Editor in Chief, Editorial Board, Journal News and the main tab Overview which includes information on the indexing and the journals table of contents.
We have also included visibility statistics next to each article in the table of contents; this enables authors to see how their paper is progressing in the journal. There is also a combined article view counter which is displayed in the Overview tab.
More indexingLibertas works with a large range of external indexing partners and regularly applies for new journals to be reviewed for inclusion in major databases. We have recently added journals to CAS, PubMed, CINAHL Complete and EMBase to name a few. Visit each journal’s home page to see where they are indexed.
Testimonials
On this brand new testimonial page you can read what our authors, peer reviewers and Editorial participants say about us. Because we value your opinion we also have a “Tell us how we are doing” link at the bottom of each web page where you can either send us your compliments or suggest any improvements to the site or our service.
Statistics
We have incorporated a Libertas Analytics page to show users just how popular our journals are. Statistics include Article views and downloads, LA Registered Users, Views of the Most Read Article and Citations of the Most Cited Article. Statistics for each journal and articles can also be found within each journal’s home page.


Fwd: Join in and make a difference.
Families of SMA
Join in and make a difference
|
|
|
|
Dear Edmund,
Volunteers Across the Country Will Hold 50 Fundraising Events in the Next Two Months for Families of SMA to Raise Funds for Research, Support and Hope.
All across the United States volunteers will come together to raise funds for critical SMA research and patient support programs. These events range from the FSMA signature Walk-n-Roll, to golf outings and fun comedy nights. Over 10,000 people will attend across the nation. Together we hope to raise $1 Million in this short time – But we need your help. Funds raised will be used to support the leading research programs directed by Families of SMA to develop a treatment and cure for SMA, along with support programs for families and critical patient care.
See below for a full list of events. It is quick and simple to participate. You can raise funds on your own, or join or lead a team.
If you do not have a local event, please consider organizing one. FSMA has support available and many tools and materials to help make your event a success.
Make a difference and join in. Your efforts will help bring us closer to a treatment and make a profound difference in your local community and to the families everywhere affected by SMA.
|
Families of SMA Programs
With your support we have funded over $50 million dollars so far directly for SMA research, including 5 new therapeutic development programs specifically for SMA: The FSMA Stem Cell program; The FSMA Quinazoline program; The FSMA Paratek Tetracycline program; and then more recently, the ISIS Oligos program, and the OSU Gene Therapy program. We have also funded 5 clinical trials with existing drugs that have potential for SMA, and the entire Project Cure clinical trial network. Our research funding model is based on relying on independent research and medical experts to evaluate and recommend which specific projects are the best to fund.
Families of SMA is a broad organization and we are involved in great programs in many areas. In addition to research, Families of SMA funds critical family support and patient care programs. These include sending information and care packages to all affected families. Families of SMA has also been hosting the Annual SMA Conference for over 22 years, which is the largest conference in the world for those affected by SMA. We are proud to offer an amazing support program for all newly diagnosed SMA families to attend our Annual SMA Conference.
|
Don’t See an Event in Your Area?
Families of SMA’s research and family support programs are funded through the grassroots fundraising efforts of our SMA families across the country. It truly is because of all our families that we are able to fund all of these projects and make progress. FSMA has support available and many tools and materials to help make your event a success. Some examples are banners, yard signs, flyers, donation cards, bracelets and much more.
If you are interested in organizing a fundraiser for FSMA or would like to learn more about the tools and information available, please contact us at (800) 886-1762 or fundraising@fsma.org.
Tips for how to promote your event throughout your local community. Click here for details. Including ideas on: Event Websites; On-line Social Networking; National Office Mailing; Community Calendars and Networks; Local Schools.
|
|
|
|
|
|
|
|
|
Families of SMA | 925 Busse Road | Elk Grove Village | IL | 60007
|


Analysis of Ashkenazi Jewish genomes (Emerson et al. 2010)
The paper hasn’t gone live at the PNAS site as of this writing, but here is part of the press release. The abstract and my comments on the paper will be posted here (after I get through the zillion other interesting papers that the last week of August seems to have brought us):
Investigators in the laboratory of Stephen Warren, PhD, chairman of human genetics at Emory University School of Medicine, used DNA microarray technology to read variant sites across the entire genomes of 471 Ashkenazi Jews. The work comes from a collaboration between Warren and Ann Pulver, ScD, associate professor of psychiatry and behavioral sciences at Johns Hopkins University School of Medicine, who recruited the participants for a study of schizophrenia genetics.
Researchers looked for close to one million single nucleotide polymorphisms (SNPs): common alternative spellings in the genome, analogous to American and British spellings of words such as organize/organise. One measure of genetic diversity in a population is heterozygosity, or how many of the SNPs inherited from the mother and father are different; a more inbred population has less heterozygosity.
“We were surprised to find evidence that Ashkenazi Jews have higher heterozygosity than Europeans, contradicting the widely-held presumption that they have been a largely isolated group,” says first author Steven Bray, PhD, a postdoctoral fellow in Warren’s laboratory.
…
High linkage disequilibrium can come either from an isolated population (for example, an island whose residents are all descendents of shipwreck survivors) or the relatively recent mixture of separate populations. Bray and his colleagues did find evidence of elevated linkage disequilibrium in the Ashkenazi Jewish population, but were able to show that this matches signs of interbreeding or “admixture” between Middle Eastern and European populations.
The researchers were able to estimate that between 35 and 55 percent of the modern Ashkenazi genome comes from European descent.
“Our study represents the largest cohort of Ashkenazi Jews examined to date with such a high density of genetic markers, and our estimate of admixture is considerably higher than previous estimates that used the Y chromosome to calculate European admixture at between five and 23 percent,” Bray says.
…
“Only six of the 21 disease genes that we examined showed evidence of selection,” Bray says. “This supports the argument that most of the Ashkenazi-prevalent diseases are not generally being selected for, but instead are likely a result of a genetic bottleneck effect, followed by random drift.”
The new paper comes in the heels of two other papers by Behar et al. and Atzmon et al. which considered Jews in general, discovering additional clusters of Jews that were distinct from Ashkenazi Jews. As I have argued in my review of these papers, the different clusters are not the result of isolation, as the different groups of Jews do not only deviate from each other, but also in the direction of their host populations. It would be worthwhile to perform similar admixture analyses on non-AJ populations to determine what their influence from host populations is. With a little effort it would be possible to reconstruct the ancestral Jewish population, by identifying what is common in the different Jewish populations.
UPDATE: The paper is now online and is open access.
From the paper:
The fixation index, FST, calculated concurrently to the PCA, confirms that there is a closer relationship between the AJ and several European populations (Tuscans, Italians, and French) than between the AJ and Middle Eastern populations (Fig. S2B). This finding can be visualized with a phylogenetic tree built using the FST data (Fig. S2C), showing that the AJ population branches with the Europeans and not Middle Easterners. Two recent studies performing PCA and population clustering with high-density SNP genotyping from many Jewish Diaspora populations, both showed that of the Jewish populations, the Ashkenazi consistently cluster closest to Europeans (13, 25). Genetic distances calculated by both groups also show that the Ashkenazi are more closely related to some host Europeans than to the ancestral Levant (13, 25). Although the proximity of the AJ and Italian populations could be explained by their admixture prior to the Ashkenazi settlement in Central Europe (13), it should be noted that different demographic models may potentially yield similar principal component projections (33); thus, it is also consistent that the projection of the AJ populations is primarily the outcome of admixture with Central and Eastern European hosts that coincidentally shift them closer to Italians along principle component axes relative to Middle Easterners. Taken as a whole, our results, along with those from previous studies, support the model of a Middle Eastern origin of the AJ population followed by subsequent admixture with host Europeans or populations more similar to Europeans. Our data further imply that modern Ashkenazi Jews are perhaps even more similar with Europeans than Middle Easterners.
The bolded part reminds me of what I wrote in my review of Atzmon et al. regarding the choice of parental populations and how they affect admixture estimates. The “Middle Eastern” component estimate will increase if central and eastern Europeans are used as representative of the European admixture, while the “European” estimate will increase if Italians are used. But, the same applies to the other end of the continuum: if ancestral Jews were indeed like current Middle Easterners such as the Druze or Palestinians, but the latter may have moved (in genetic space) away from ancient Levantines due to subsequent admixture (Arabs, and in the case of Palestinians even Africans): this would reduce the inferred Middle Eastern component.
Estimating admixture percentages in the absence of clear knowledge about parental populations is no easy thing, but the intermediate-leaning-on-Europe status of AJ relative to living Europeans and living Middle Easterners seems to be a pretty secure conclusion.
PNAS doi: 10.1073/pnas.1006538107
Resolving postglacial phylogeography using high-throughput sequencing
Kevin J. Emerson et al.
The Ashkenazi Jewish (AJ) population has long been viewed as a genetic isolate, yet it is still unclear how population bottlenecks, admixture, or positive selection contribute to its genetic structure. Here we analyzed a large AJ cohort and found higher linkage disequilibrium (LD) and identity-by-descent relative to Europeans, as expected for an isolate. However, paradoxically we also found higher genetic diversity, a sign of an older or more admixed population but not of a long-term isolate. Recent reports have reaffirmed that the AJ population has a common Middle Eastern origin with other Jewish Diaspora populations, but also suggest that the AJ population, compared with other Jews, has had the most European admixture. Our analysis indeed revealed higher European admixture than predicted from previous Y-chromosome analyses. Moreover, we also show that admixture directly correlates with high LD, suggesting that admixture has increased both genetic diversity and LD in the AJ population. Additionally, we applied extended haplotype tests to determine whether positive selection can account for the level of AJ-prevalent diseases. We identified genomic regions under selection that account for lactose and alcohol tolerance, and although we found evidence for positive selection at some AJ-prevalent disease loci, the higher incidence of the majority of these diseases is likely the result of genetic drift following a bottleneck. Thus, the AJ population shows evidence of past founding events; however, admixture and selection have also strongly influenced its current genetic makeup.
Link

More structure in haplogroup R1b (Cruciani et al. 2010)
The stack of exciting papers to read keeps growing. Good things come in pairs for R1b folk.
Forensic Science International: Genetics doi:10.1016/j.fsigen.2010.07.006
Strong intra- and inter-continental differentiation revealed by Y chromosome SNPs M269, U106 and U152
Fulvio Cruciani et al.
More than 2700 unrelated individuals from Europe, northern Africa and western Asia were analyzed for the marker M269, which defines the Y chromosome haplogroup R1b1b2. A total of 593 subjects belonging to this haplogroup were identified and further analyzed for two SNPs,
U106 and U152, which define haplogroups R1b1b2g and R1b1b2h, respectively. These haplogroups showed quite different frequency distribution patterns within Europe, with frequency
peaks in northern Europe (R1b1b2g) and northern Italy/France (R1b1b2h).
Link

Research Funding
I have an opportunity to fund a research of my choosing. Not a lot of money. About $2,000.
Questions for the readers that have directed funded a research before:
- What research would you fund? Which one seems most promising to you?
- $2,000 seems quite small for a research project. How did you approach the researcher?
Other thoughts are welcome as well.